The field of biopharma has always been at the forefront of global scientific, medical, and commercial innovation. From gene editing and personalized medicine to cell therapy and novel treatment options, biopharma is evolving at an unprecedented pace, offering new therapeutic choices to patients worldwide.

The 4th World Congress of Biopharm Industry Development (BID-2025) will take place in Fengxian, Shanghai, from September 24-26, 2025, with the theme “Bridging Global High-end Talents, Empowering Industrial Innovation”. This conference aims to be one of the most significant events in the global biopharma field in 2025, providing an exceptional platform for exchange, collaboration, and the shaping of the future direction of the biopharmaceutical industry.

The conference will feature a variety of activities, including: Keynote speeches by leading experts, scientific forums and panel discussions, Exhibitions and poster presentations, Networking opportunities, Site visits. In addition, seven specialized forums will focus on key areas of biopharma, including: Frontier Research in Drug Discovery, Cutting-Edge Drug Discovery Technologies, Drug Discovery Chemistry Innovation, Novel Drug Delivery Technologies and Systems, Gene and Cell Therapy Innovation & Development, Next-Generation Protein and Peptide Drugs, Pharmaceutical Process Development & Manufacturing.